Sight Diagnostics
Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.
About
Sight Diagnostics aims to improve health outcomes through fast, accurate, and convenient diagnostic testing. Their flagship product, Sight OLO, is a compact analyzer that performs a Complete Blood Count (CBC), the most commonly ordered blood test, in minutes, providing critical information for timely treatment decisions. Teams look it up for Healthcare, Diagnostics, Blood.
Frequently asked
What does Sight Diagnostics do?
Sight Diagnostics is a Healthcare company that offers Software. Teams look it up for Diagnostics, Blood, MedTech. It is based in Tel Aviv, Israel and was founded in 2011. Public records show about 65 people and $124M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Sight Diagnostics raised?
Sight Diagnostics has raised a total of $124M in funding. The most recent round on record is Series D.
Where is Sight Diagnostics headquartered?
Sight Diagnostics is headquartered in Tel Aviv, Israel.
When was Sight Diagnostics founded?
Sight Diagnostics was founded in 2011.
What industry does Sight Diagnostics operate in?
Sight Diagnostics operates in Healthcare, Diagnostics, Blood, MedTech, HealthTech.
How many employees does Sight Diagnostics have?
Sight Diagnostics has approximately 65 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
“I heard of a company trying to do what Holmes and Theranos did (before they turned bad), called Sight Diagnostics, from Tel Aviv (I think), and some other companies like Vital Biosciences (SF, backed by Sam Altman of OpenAI) and Babson Diag…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.